RACHELLE DOODY to Asymptomatic Diseases
This is a "connection" page, showing publications RACHELLE DOODY has written about Asymptomatic Diseases.
Connection Strength
0.249
-
Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer's disease. Alzheimers Res Ther. 2022 11 29; 14(1):178.
Score: 0.204
-
Platform Trials to Expedite Drug Development in Alzheimer's Disease: A Report from the EU/US CTAD Task Force. J Prev Alzheimers Dis. 2021; 8(3):306-312.
Score: 0.045